-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
MiNK Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q1 2024.
- MiNK Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $53.8K, a 17.8% increase year-over-year.
- MiNK Therapeutics, Inc. annual Depreciation for 2023 was $205K, a 68.1% increase from 2022.
- MiNK Therapeutics, Inc. annual Depreciation for 2022 was $122K, a 56.2% increase from 2021.
- MiNK Therapeutics, Inc. annual Depreciation for 2021 was $78K, a 41.6% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)